Report cover image

Global Opioid Analgesics Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published May 17, 2025
Length 191 Pages
SKU # APRC20361315

Description

Summary

According to APO Research, The global Opioid Analgesics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Opioid Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Opioid Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Opioid Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Opioid Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Opioid Analgesics include Assertio Holdings, Inc, Bausch Health, Boehringer Ingelheim International GmbH, Endo International Plc, F. Hoffmann-La Roche AG, Purdue Pharmaceuticals L.P., Sanofi S.A., Teva Pharmaceuticals and Abbott Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Opioid Analgesics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Opioid Analgesics, also provides the sales of main regions and countries. Of the upcoming market potential for Opioid Analgesics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Opioid Analgesics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Opioid Analgesics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Opioid Analgesics sales, projected growth trends, production technology, application and end-user industry.

Opioid Analgesics Segment by Company

Assertio Holdings, Inc
Bausch Health
Boehringer Ingelheim International GmbH
Endo International Plc
F. Hoffmann-La Roche AG
Purdue Pharmaceuticals L.P.
Sanofi S.A.
Teva Pharmaceuticals
Abbott Laboratories
Bayer AG
GlaxoSmithKline plc
Pfizer Inc.
Novartis AG
Johnson & Johnson
Opioid Analgesics Segment by Type

Morphine
Methadone
OxyContin
Vicodin
Others
Opioid Analgesics Segment by Application

Surgical Pain
Neuropathic Pain
Cancer Pain
Others
Opioid Analgesics Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Analgesics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Opioid Analgesics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Opioid Analgesics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioid Analgesics sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Opioid Analgesics Market by Type
1.2.1 Global Opioid Analgesics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Morphine
1.2.3 Methadone
1.2.4 OxyContin
1.2.5 Vicodin
1.2.6 Others
1.3 Opioid Analgesics Market by Application
1.3.1 Global Opioid Analgesics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Surgical Pain
1.3.3 Neuropathic Pain
1.3.4 Cancer Pain
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Opioid Analgesics Market Dynamics
2.1 Opioid Analgesics Industry Trends
2.2 Opioid Analgesics Industry Drivers
2.3 Opioid Analgesics Industry Opportunities and Challenges
2.4 Opioid Analgesics Industry Restraints
3 Global Market Growth Prospects
3.1 Global Opioid Analgesics Revenue Estimates and Forecasts (2020-2031)
3.2 Global Opioid Analgesics Revenue by Region
3.2.1 Global Opioid Analgesics Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Opioid Analgesics Revenue by Region (2020-2025)
3.2.3 Global Opioid Analgesics Revenue by Region (2026-2031)
3.2.4 Global Opioid Analgesics Revenue Market Share by Region (2020-2031)
3.3 Global Opioid Analgesics Sales Estimates and Forecasts 2020-2031
3.4 Global Opioid Analgesics Sales by Region
3.4.1 Global Opioid Analgesics Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Opioid Analgesics Sales by Region (2020-2025)
3.4.3 Global Opioid Analgesics Sales by Region (2026-2031)
3.4.4 Global Opioid Analgesics Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Opioid Analgesics Revenue by Manufacturers
4.1.1 Global Opioid Analgesics Revenue by Manufacturers (2020-2025)
4.1.2 Global Opioid Analgesics Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Opioid Analgesics Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Opioid Analgesics Sales by Manufacturers
4.2.1 Global Opioid Analgesics Sales by Manufacturers (2020-2025)
4.2.2 Global Opioid Analgesics Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Opioid Analgesics Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Opioid Analgesics Sales Price by Manufacturers (2020-2025)
4.4 Global Opioid Analgesics Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Opioid Analgesics Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Opioid Analgesics Manufacturers, Product Type & Application
4.7 Global Opioid Analgesics Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Opioid Analgesics Market CR5 and HHI
4.8.2 2024 Opioid Analgesics Tier 1, Tier 2, and Tier 3
5 Opioid Analgesics Market by Type
5.1 Global Opioid Analgesics Revenue by Type
5.1.1 Global Opioid Analgesics Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Opioid Analgesics Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Opioid Analgesics Revenue Market Share by Type (2020-2031)
5.2 Global Opioid Analgesics Sales by Type
5.2.1 Global Opioid Analgesics Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Opioid Analgesics Sales by Type (2020-2031) & (Tons)
5.2.3 Global Opioid Analgesics Sales Market Share by Type (2020-2031)
5.3 Global Opioid Analgesics Price by Type
6 Opioid Analgesics Market by Application
6.1 Global Opioid Analgesics Revenue by Application
6.1.1 Global Opioid Analgesics Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Opioid Analgesics Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Opioid Analgesics Revenue Market Share by Application (2020-2031)
6.2 Global Opioid Analgesics Sales by Application
6.2.1 Global Opioid Analgesics Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Opioid Analgesics Sales by Application (2020-2031) & (Tons)
6.2.3 Global Opioid Analgesics Sales Market Share by Application (2020-2031)
6.3 Global Opioid Analgesics Price by Application
7 Company Profiles
7.1 Assertio Holdings, Inc
7.1.1 Assertio Holdings, Inc Comapny Information
7.1.2 Assertio Holdings, Inc Business Overview
7.1.3 Assertio Holdings, Inc Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Assertio Holdings, Inc Opioid Analgesics Product Portfolio
7.1.5 Assertio Holdings, Inc Recent Developments
7.2 Bausch Health
7.2.1 Bausch Health Comapny Information
7.2.2 Bausch Health Business Overview
7.2.3 Bausch Health Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Bausch Health Opioid Analgesics Product Portfolio
7.2.5 Bausch Health Recent Developments
7.3 Boehringer Ingelheim International GmbH
7.3.1 Boehringer Ingelheim International GmbH Comapny Information
7.3.2 Boehringer Ingelheim International GmbH Business Overview
7.3.3 Boehringer Ingelheim International GmbH Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio
7.3.5 Boehringer Ingelheim International GmbH Recent Developments
7.4 Endo International Plc
7.4.1 Endo International Plc Comapny Information
7.4.2 Endo International Plc Business Overview
7.4.3 Endo International Plc Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Endo International Plc Opioid Analgesics Product Portfolio
7.4.5 Endo International Plc Recent Developments
7.5 F. Hoffmann-La Roche AG
7.5.1 F. Hoffmann-La Roche AG Comapny Information
7.5.2 F. Hoffmann-La Roche AG Business Overview
7.5.3 F. Hoffmann-La Roche AG Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio
7.5.5 F. Hoffmann-La Roche AG Recent Developments
7.6 Purdue Pharmaceuticals L.P.
7.6.1 Purdue Pharmaceuticals L.P. Comapny Information
7.6.2 Purdue Pharmaceuticals L.P. Business Overview
7.6.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio
7.6.5 Purdue Pharmaceuticals L.P. Recent Developments
7.7 Sanofi S.A.
7.7.1 Sanofi S.A. Comapny Information
7.7.2 Sanofi S.A. Business Overview
7.7.3 Sanofi S.A. Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Sanofi S.A. Opioid Analgesics Product Portfolio
7.7.5 Sanofi S.A. Recent Developments
7.8 Teva Pharmaceuticals
7.8.1 Teva Pharmaceuticals Comapny Information
7.8.2 Teva Pharmaceuticals Business Overview
7.8.3 Teva Pharmaceuticals Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Teva Pharmaceuticals Opioid Analgesics Product Portfolio
7.8.5 Teva Pharmaceuticals Recent Developments
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Comapny Information
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Abbott Laboratories Opioid Analgesics Product Portfolio
7.9.5 Abbott Laboratories Recent Developments
7.10 Bayer AG
7.10.1 Bayer AG Comapny Information
7.10.2 Bayer AG Business Overview
7.10.3 Bayer AG Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Bayer AG Opioid Analgesics Product Portfolio
7.10.5 Bayer AG Recent Developments
7.11 GlaxoSmithKline plc
7.11.1 GlaxoSmithKline plc Comapny Information
7.11.2 GlaxoSmithKline plc Business Overview
7.11.3 GlaxoSmithKline plc Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 GlaxoSmithKline plc Opioid Analgesics Product Portfolio
7.11.5 GlaxoSmithKline plc Recent Developments
7.12 Pfizer Inc.
7.12.1 Pfizer Inc. Comapny Information
7.12.2 Pfizer Inc. Business Overview
7.12.3 Pfizer Inc. Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Pfizer Inc. Opioid Analgesics Product Portfolio
7.12.5 Pfizer Inc. Recent Developments
7.13 Novartis AG
7.13.1 Novartis AG Comapny Information
7.13.2 Novartis AG Business Overview
7.13.3 Novartis AG Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Novartis AG Opioid Analgesics Product Portfolio
7.13.5 Novartis AG Recent Developments
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Comapny Information
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Johnson & Johnson Opioid Analgesics Product Portfolio
7.14.5 Johnson & Johnson Recent Developments
8 North America
8.1 North America Opioid Analgesics Market Size by Type
8.1.1 North America Opioid Analgesics Revenue by Type (2020-2031)
8.1.2 North America Opioid Analgesics Sales by Type (2020-2031)
8.1.3 North America Opioid Analgesics Price by Type (2020-2031)
8.2 North America Opioid Analgesics Market Size by Application
8.2.1 North America Opioid Analgesics Revenue by Application (2020-2031)
8.2.2 North America Opioid Analgesics Sales by Application (2020-2031)
8.2.3 North America Opioid Analgesics Price by Application (2020-2031)
8.3 North America Opioid Analgesics Market Size by Country
8.3.1 North America Opioid Analgesics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Opioid Analgesics Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Opioid Analgesics Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Opioid Analgesics Market Size by Type
9.1.1 Europe Opioid Analgesics Revenue by Type (2020-2031)
9.1.2 Europe Opioid Analgesics Sales by Type (2020-2031)
9.1.3 Europe Opioid Analgesics Price by Type (2020-2031)
9.2 Europe Opioid Analgesics Market Size by Application
9.2.1 Europe Opioid Analgesics Revenue by Application (2020-2031)
9.2.2 Europe Opioid Analgesics Sales by Application (2020-2031)
9.2.3 Europe Opioid Analgesics Price by Application (2020-2031)
9.3 Europe Opioid Analgesics Market Size by Country
9.3.1 Europe Opioid Analgesics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Opioid Analgesics Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Opioid Analgesics Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Opioid Analgesics Market Size by Type
10.1.1 China Opioid Analgesics Revenue by Type (2020-2031)
10.1.2 China Opioid Analgesics Sales by Type (2020-2031)
10.1.3 China Opioid Analgesics Price by Type (2020-2031)
10.2 China Opioid Analgesics Market Size by Application
10.2.1 China Opioid Analgesics Revenue by Application (2020-2031)
10.2.2 China Opioid Analgesics Sales by Application (2020-2031)
10.2.3 China Opioid Analgesics Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Opioid Analgesics Market Size by Type
11.1.1 Asia Opioid Analgesics Revenue by Type (2020-2031)
11.1.2 Asia Opioid Analgesics Sales by Type (2020-2031)
11.1.3 Asia Opioid Analgesics Price by Type (2020-2031)
11.2 Asia Opioid Analgesics Market Size by Application
11.2.1 Asia Opioid Analgesics Revenue by Application (2020-2031)
11.2.2 Asia Opioid Analgesics Sales by Application (2020-2031)
11.2.3 Asia Opioid Analgesics Price by Application (2020-2031)
11.3 Asia Opioid Analgesics Market Size by Country
11.3.1 Asia Opioid Analgesics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Opioid Analgesics Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Opioid Analgesics Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Opioid Analgesics Market Size by Type
12.1.1 SAMEA Opioid Analgesics Revenue by Type (2020-2031)
12.1.2 SAMEA Opioid Analgesics Sales by Type (2020-2031)
12.1.3 SAMEA Opioid Analgesics Price by Type (2020-2031)
12.2 SAMEA Opioid Analgesics Market Size by Application
12.2.1 SAMEA Opioid Analgesics Revenue by Application (2020-2031)
12.2.2 SAMEA Opioid Analgesics Sales by Application (2020-2031)
12.2.3 SAMEA Opioid Analgesics Price by Application (2020-2031)
12.3 SAMEA Opioid Analgesics Market Size by Country
12.3.1 SAMEA Opioid Analgesics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Opioid Analgesics Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Opioid Analgesics Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Opioid Analgesics Value Chain Analysis
13.1.1 Opioid Analgesics Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Opioid Analgesics Production Mode & Process
13.2 Opioid Analgesics Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Opioid Analgesics Distributors
13.2.3 Opioid Analgesics Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.